Literature DB >> 8389074

Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.

D Derse1, S H Newbold.   

Abstract

Certain members of the lentivirus subfamily of retroviruses encode unique transcriptional activator (Tat) proteins that modify the transcription complex after binding to the 5' end of nascent viral mRNA. The Tat proteins are modular, containing RNA-binding and activation domains that can be exchanged between different Tat proteins or replaced with heterologous protein fragments. While there is considerable sequence conservation among the divergent Tat proteins, there are also some structural differences that might be informative. For example, a cluster of basic amino acids in HIV-1 Tat is sufficient for RNA binding in vivo and in vitro. The homologous region of EIAV Tat is necessary but not sufficient for recognition of its cognate cis-acting RNA element; the entire C-terminal 26 amino acids of EIAV Tat, including the basic patch, are required. To better understand the structure-function relationships in EIAV Tat, we have generated a battery of expression plasmids encoding insertion, deletion, and missense mutations in the carboxy-terminal region of the tat gene. The plasmids were tested for their ability to trans-activate the EIAV promoter or to trans-inhibit a heterologous Tat protein. A mutation of a glutamine to an arginine in the cluster of basic residues generated a potent trans-dominant inhibitor of both EIAV and HIV-1 Tat, indicating that the mutation abolished RNA binding but did not alter the activation domain. Mutations at the extreme C-terminus of EIAV Tat impaired both RNA binding and activation domain functions, suggesting effects on secondary or tertiary structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389074     DOI: 10.1006/viro.1993.1291

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

2.  Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Authors:  R Taube; K Fujinaga; D Irwin; J Wimmer; M Geyer; B M Peterlin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus.

Authors:  D W Hoffman; S W White
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

4.  Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.

Authors:  M Vanden Haesevelde; J L Decourt; R J De Leys; B Vanderborght; G van der Groen; H van Heuverswijn; E Saman
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

6.  Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.

Authors:  Daniel C Farley; Richard Bannister; Marie A Leroux-Carlucci; Nerys E Evans; James E Miskin; Kyriacos A Mitrophanous
Journal:  Hum Gene Ther Methods       Date:  2012-11-02       Impact factor: 2.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.